(Newswire.net — June 1, 2017) New York , NY — The global peptic ulcer drugs treatment market was valued at US$ 32,200 million in 2014. North America led the global market 2014, accounting for 41.2% share of total global market revenue. The surge in use of non-steroidal anti-inflammatory drugs (NSAID) such as aspirin and growing awareness regarding treatment options for peptic ulcers are factors expected to drive the growth of the peptic ulcer drugs market in North America. The market in Europe accounted for a second largest share of 25.8%, primarily due to easy availability of successful treatment options for peptic ulcers in the region.
Revenue from the global peptic ulcer drugs market is projected to expand at a steady CAGR of 2.8% over the forecast period and is expected to be valued at US$ 40,004.3 million by 2022 end. North America is expected to remain the dominant market, contributing 41.5% share to the global peptic ulcer drugs market in terms of revenue. The PPI and H2 antagonist product segments collectively accounted for 79.2% revenue share in 2014. The gastric ulcer indication segment was valued at US$ 5,279.8 million in 2014 and is expected to register the highest CAGR of 3.0% over the forecast period.
View Report Table of Contents, Figures, and Tables@ http://www.persistencemarketresearch.com/market-research/peptic-ulcer-drugs-market/toc
Factors driving the growth of the global peptic ulcer drugs market include growing prevalence of peptic ulcers, increasing adoption of peptic ulcer drugs over surgery, R&D stimulation through government policies, increasing the number of generic manufacturers of peptic ulcer drugs, changes in disease management etc. Furthermore, factors such as growing prevalence of stress-induced ulcers due to changing lifestyle and diet, increasing smoking rate, and progressive population of geriatrics are anticipated to promote the growth of the global peptic ulcer drugs market over the forecast period. However, side effects of peptic ulcer drugs, poor pipeline productivity, and changes in pricing policies of drugs are factors expected to hamper the growth of the global peptic ulcer drugs market during this period.
Top players in the global peptic ulcer drugs market covered in this report are Daewoong Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Pfizer Inc., Abbott Laboratories, AstraZeneca plc., Cadila Healthcare Ltd., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, and GlaxoSmithKline Plc.
A sample of this report is available upon request@ http://www.persistencemarketresearch.com/samples/3704
About Persistence Market Research
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
305 Broadway, 7th FloorNew York, NY 10007
United States
+1-646-568-7751
sales@persitencemarketreserach.com
http://www.persistencemarketresearch.com
About Persistence Market Research
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
305 Broadway, 7th FloorNew York , NY 10007
United States
+1-646-568-7751
sales@persitencemarketreserach.com
http://www.persistencemarketresearch.com